Pacira Pharmaceuticals Announces FDA Acceptance of Exparel New Drug Application for Pain Management
Links shared publicly online about this topic.
- 636total visits
Pacira Pharmaceuticals Announces FDA Acceptance of Exparel New Drug Application for Pain Management
Exparel (bupivacaine) is a new drug in development for postsurgical pain management. Exparel information includes news, clinical trial results and side effects.
View full resource at drugs.com
Tags: Pain Management, Pain, Drug, Pharma, Clinical Trial, FDA, News
Most Recently Shared on December 22, 2010 at 10:02 pm By:
Pacira Pharmaceuticals Announces FDA Acceptance of Exparel New Drug Application for Pain Management: PARSI... http://bit.ly/fnOehk #drug
Advertisement
